Evolent Health (EVH) Share-based Compensation (2015 - 2026)

Evolent Health's Share-based Compensation history runs 12 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Share-based Compensation fell 83.61% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was -$4.0 million, a 132.45% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, down 66.71% from the prior year.
• Share-based Compensation rose to $1.8 million in Q1 2026 per EVH's latest filing, from $58000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $31.2 million in Q3 2024 and bottomed at -$30.2 million in Q4 2024.
• The 5-year median for Share-based Compensation is $7.1 million (2023), against an average of $5.7 million.
• Across the five-year window, Share-based Compensation jumped 337.51% in 2022 and slumped 1874.73% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $14.6 million in 2022, then retreated by 27.53% to $10.6 million in 2023, then plunged by 384.47% to -$30.2 million in 2024, then soared by 100.19% to $58000.0 in 2025, then surged by 3031.03% to $1.8 million in 2026.
• Per Business Quant, the three latest EVH Share-based Compensation figures stand at $1.8 million (Q1 2026), $58000.0 (Q4 2025), and $547000.0 (Q3 2025).